Access Statistics for Mary K. Olson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Pharmaceutical Expenditure and Regulatory Policy in the NHS 0 0 0 0 0 0 0 329
Total Working Papers 0 0 0 0 0 0 0 329


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Agency Rulemaking, Political Influences, Regulation, and Industry Compliance 0 0 0 0 0 1 4 354
Are novel drugs more risky for patients than less novel drugs? 0 0 1 27 0 0 2 99
Eliminating the U.S. drug lag: Implications for drug safety 0 0 0 10 0 0 5 90
Examining Firm Responses to R&D Policy: An Analysis of Pediatric Exclusivity 0 0 0 2 1 3 16 34
Firm Characteristics and the Speed of FDA Approval 0 1 2 40 0 1 7 133
Pharmaceutical Policy Change and the Safety of New Drugs 0 0 0 3 3 5 10 56
Political Influence and Regulatory Policy: The 1984 Drug Legislation 0 0 0 0 0 0 1 173
Regulatory Agency Discretion among Competing Industries: Inside the FDA 0 0 0 0 0 0 2 174
Regulatory Reform and Bureaucratic Responsiveness to Firms: the Impact of User Fees in the FDA 0 0 0 24 0 0 2 114
Substitution in Regulatory Agencies: FDA Enforcement Alternatives 0 0 0 0 0 0 1 190
The Effects of UK Pharmaceutical Policy on Government Drug Expenditure: Cost Control and Incentives for R&D 0 0 0 12 0 0 0 62
The risk we bear: The effects of review speed and industry user fees on new drug safety 0 0 1 23 0 0 3 115
Total Journal Articles 0 1 4 141 4 10 53 1,594


Statistics updated 2020-11-03